Languages: English, Spanish
Jeffrey Vacirca, MD, FACP is a board-certified hematologist and oncologist at New York Cancer & Blood Specialists, where he serves as CEO and managing partner.
Dr. Vacirca is the immediate past president of the Community Oncology Alliance (COA), medical director for Amerisource Bergen specialty group, a Scientific Advisory Board Member for Caris Life Sciences, director at OneOncology, Director at Spectrum Pharmaceuticals and serves as a medical board advisor for Flatiron Health, located in New York City. Additionally, he is vice-chairman of the board for Odonate Therapeutics, a company he founded in 2016 which is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. He was a recipient of the Theodore Roosevelt Award for outstanding dedication to patient care and has been named in Newsday’s Top Doctors. Dr. Vacirca serves as a consulting physician for the Long Island Association for AIDS Care and was honored for his role in enabling LIAAC staff to bring state of the art HIV testing to New York.
In 2014, Dr. Vacirca founded the New York Cancer Foundation, of which he is the chair of the board of directors. The Foundation provides financial assistance to patients undergoing treatment for cancer. Since its inception, the New York Cancer Foundation has helped hundreds of patients and their families with non-medical expenses including rent, mortgage, utility bills, and transportation to and from treatment.
|Port Jefferson Medical Oncology||1500 Route 112, Building 4, Port Jefferson Station, NY 11776||+1 (855) 528-7322|
|Mt. Sinai Medical Center|